Why Medifast Inc’s (MED) Stock Is Down 5.46% (2024)

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Medifast Inc before investing.

In this article, we go over a few key elements for understanding Medifast Inc’s stock price such as:

Before we jump into Medifast Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Medifast, Inc. is a health and wellness company. The Company provides a habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a comprehensive approach to help them achieve lasting optimal health and wellbeing. OPTAVIA's lifestyle plans deliver clinically proven health benefits as well as evidence-based tools, including scientifically developed products and a framework for habit creation reinforced by independent coaches and community support. Through a collaboration with the virtual primary care provider LifeMD, Inc (LifeMD), OPTAVIA customers have access to board-certified affiliated clinicians and medications, such as GLP-1s, that support treatment plans for obesity and other health conditions. OPTAVIA Coaches introduce customers to a set of healthy habits, and offer OPTAVIA-branded products, including Fuelings as well as OPTAVIA ACTIVE, a line of essential amino acid supplements and protein powders. Its operations are conducted through its subsidiaries.

Want to learn more about Medifast Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Medifast Inc.

As of July 05, 2024, 4:00 PM, CST, Medifast Inc’s stock price was $18.69.

Medifast Inc is down 5.46% from its previous closing price of $19.77.

During the last market session, Medifast Inc’s stock traded between $19.75 and $20.68. Currently, there are 10.91 million shares of Medifast Inc stock available for purchase.

Medifast Inc’s price-earnings (P/E) ratio is currently at 3.2, which is low compared to the Food Processing industry median of 18.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Medifast Inc’s (MED) price is currently down 14.34% so far this month.

During the month of July, Medifast Inc’s stock price has reached a high of $22.21 and a low of $18.66.

Over the last year, Medifast Inc has hit prices as high as $109.52 and as low as $18.81. Year to date, Medifast Inc’s stock is down 83.8%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 03, 2024, there were 0 analysts who downgraded Medifast Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Medifast Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Medifast Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Medifast Inc’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Medifast Inc (MED) by visiting AAII Stock Evaluator.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 03, 2024, Medifast Inc has a weighted four-quarter relative price strength of -36.11%, which translates to a Momentum Score of 7 and is considered to be Very Weak.

Want to learn more about how Medifast Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

As of July 5, 2024, Medifast Inc’s stock price is $18.69, which is down 5.46% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Medifast Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.